Michael Sela

Michael Sela
Michael Sela
מיכאל סלע
	Michael Sela
Born	Mieczysław Salomonowicz; 2 March 1924; Tomaszów Mazowiecki, Poland
Died	27 May 2022 (aged 98)
Nationality	Israeli
Occupation	immunologist
Known for	Research in immunology; President of the Weizmann Institute of Science;
Title	W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science
Awards	The Israel Prize in Life Sciences (1959); Germany's Otto Warburg Medal (1968); The Rothschild Prize (1968); Canada's Gairdner Foundation International Award (1980); Germany's Commander's Cross of the Order of Merit Award (1986); France's Officier de l'Ordre de la Légion d'honneur (1987); Interbrew-Baillet Latour Health Prize of Belgium (1997); The Wolf Prize in Medicine (1998);

Michael Sela (Hebrew: מיכאל סלע; Mieczysław Salomonowicz; 2 March 1924 – 27 May 2022) was a Polish-born Israeli immunologist. He was the W. Garfield Weston Professor of Immunology at the Weizmann Institute of Science in Rehovot.^[1] He was the president of the Weizmann Institute of Science from 1975 until 1985.^[2] He was probably best known as the co-developer (with Ruth Arnon and Dvora Teitelbaum) of the multiple sclerosis drug copaxone.

Sela died on 27 May 2022 at the age of 98.^[3]